ArticleMedicine2026
Perioperative outcomes and risk factors following common femoral endarterectomy: A multicenter retrospective study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Common femoral endarterectomy (CFE) remains essential in the endovascular era for treating common femoral artery disease and enabling hybrid revascularization. Despite its widespread use, contemporary data on outcomes and risk factors are limited. This retrospective multicenter study analyzed 150 consecutive CFE procedures performed at 2 Korean centers between January 2017 and February 2024. The primary endpoints were 6-month all-cause mortality and 3-month local complications. Univariate logistic regression was performed to identify potential risk factors. Although CFE is technically straightforward, it has meaningful perioperative risks, particularly in patients with chronic kidney disease, high American Society of Anesthesiologists scores, or chronic limb-threatening ischemia (CLTI). These findings underscore the importance of careful patient selection and perioperative optimization and highlight the need for vigilant postoperative monitoring even for this commonly performed procedure. The cohort included 150 limbs from 132 patients (mean age 72.2 ± 9.8 years; 72.7% male). Clinical presentations included claudication (45.3%), chronic limb-threatening ischemia (CLTI; 36.7%), acute limb ischemia (12.7%), and access-related indications (5.3%). Combined procedures were performed in 86.7% of the patients. The 6-month mortality rate was 6.7% (10/150), and 3-month local complications occurred in 7.3% of patients (11/150). The significant risk factors for mortality according to the univariate analysis included chronic kidney disease (odds ratio [OR] 4.19; 95% confidence interval [CI] 1.13-15.49; P = .037), an American Society of Anesthesiologists score ≥ 4 (OR 7.75; 95% CI 2.02-29.73; P = .005), and CLTI (OR 4.47; 95% CI 1.11-18.08; P = .038). A body mass index > 25 kg/m2 was significantly associated with local complications (OR 4.01, 95% CI 1.15-14.02; P = .031). Subgroup analysis revealed no significant difference in outcomes between isolated CFE (n = 36) and combined CFE (n = 114).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.